Further Information
Targeting protein for Xklp2, Differentially expressed in cancerous and non-cancerous lung cells 2, DIL-2, Hepatocellular carcinoma-associated antigen 519, Hepatocellular carcinoma-associated antigen 90, Protein fls353, Restricted expression proliferation-associated protein 100, p100, TPX2, C20orf1, C20orf2, DIL2, HCA519
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:50~100
The nuclear protein p100 is a proliferation-associated protein whose expression is restricted to cell cycle phases S, G2, and M. Exclusively expressed in proliferating cells from the transition G1/S until the end of cytokinesis. During mitosis it is strictly associated with the spindle pole and with the mitotic spindle, whereas during S and G2, it is diffusely distributed throughout the nucleus. The full-length cDNA encodes a 747-amino acid protein with a putative ATP/GTP-binding site motif. RT-PCR analysis demonstrated strong expression of in lung carcinoma cell lines but not in normal lung tissues. Expression was also found in adult placenta, skeletal muscle, thymus, testis, and small intestine and in fetal brain, liver, and kidney. P100 is also correlated to cancer prognosis.
- Ota, T., et al., Nat. Genet. 36(1):40-45 (2004).
- Heidebrecht, H.J., et al., Mol. Cancer Res. 1(4):271-279 (2003).
- Garrett, S., et al., Curr. Biol. 12(23):2055-2059 (2002).
- Gruss, O.J., et al., Nat. Cell Biol. 4(11):871-879 (2002).
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
This P100 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 350-382 amino acids from human P100.
22974
Targeting protein for Xklp2
TPX2
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
86 kDa
Q9ULW0
13124096
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
Cancer,Cell Cycle
Q9ULW0
Optimal dilutions for each application to be determined by the researcher.